Literature DB >> 1365909

p53 loss of function: implications for the processes of immortalization and tumorigenesis.

C A Finlay1.   

Abstract

The complex process of cell immortalization and transformation is likely to involve the inactivation of growth regulatory genes. Mutations (deletions, missense mutations) in the p53 gene are the most frequently observed genetic alteration in human tumors, making p53 a candidate for a cellular protein involved in the control of cell growth. Two recent studies have examined the role of p53 in immortalization and tumorigenesis. In the first study, p53 expression was examined in both mortal and immortal chick embryo fibroblasts. All mortal clones expressed p53 but the loss of wild-type p53 expression was observed in every immortal cell line examined. In the second study, a line of mice carrying two null p53 alleles has been created and characterized. Although these mice develop normally, they show a predisposition to develop a variety of neoplasms at an early age (< 6 months). Although it is unclear whether p53 regulates the same, different, or overlapping pathways in the two experimental systems, these data demonstrate that p53 function is critical for the maintenance of normal growth control and support the current classification of p53 as a growth suppressive or tumor suppressor gene.

Entities:  

Mesh:

Substances:

Year:  1992        PMID: 1365909     DOI: 10.1002/bies.950140811

Source DB:  PubMed          Journal:  Bioessays        ISSN: 0265-9247            Impact factor:   4.345


  8 in total

1.  Loss-of-function genetics in mammalian cells: the p53 tumor suppressor model.

Authors:  A Carnero; J D Hudson; G J Hannon; D H Beach
Journal:  Nucleic Acids Res       Date:  2000-06-01       Impact factor: 16.971

2.  Mutation of p53 in primary biopsy material and cell lines from Hodgkin disease.

Authors:  R K Gupta; K Patel; W F Bodmer; J G Bodmer
Journal:  Proc Natl Acad Sci U S A       Date:  1993-04-01       Impact factor: 11.205

3.  Immunohistochemical features of the human retina and retinoblastoma.

Authors:  K Yuge; M Nakajima; Y Uemura; H Miki; M Uyama; A Tsubura
Journal:  Virchows Arch       Date:  1995       Impact factor: 4.064

4.  p53 exon 5 mutations as a prognostic indicator of shortened survival in non-small-cell lung cancer.

Authors:  F J Vega; P Iniesta; T Caldés; A Sanchez; J A López; C de Juan; E Diaz-Rubio; A Torres; J L Balibrea; M Benito
Journal:  Br J Cancer       Date:  1997       Impact factor: 7.640

Review 5.  Genetically engineered mouse models in oncology research and cancer medicine.

Authors:  Kelly Kersten; Karin E de Visser; Martine H van Miltenburg; Jos Jonkers
Journal:  EMBO Mol Med       Date:  2017-02       Impact factor: 12.137

Review 6.  Mouse models in the era of large human tumour sequencing studies.

Authors:  J R de Ruiter; L F A Wessels; J Jonkers
Journal:  Open Biol       Date:  2018-08       Impact factor: 6.411

7.  An LDV based method to quantify the error of PC-MRI derived Wall Shear Stress measurement.

Authors:  Marco Castagna; Sébastien Levilly; Perrine Paul-Gilloteaux; Saïd Moussaoui; Jean-Marc Rousset; Félicien Bonnefoy; Jérôme Idier; Jean-Michel Serfaty; David Le Touzé
Journal:  Sci Rep       Date:  2021-02-18       Impact factor: 4.379

8.  Effects of high glucose conditions on the expansion and differentiation capabilities of mesenchymal stromal cells derived from rat endosteal niche.

Authors:  Ahmed Makki A Al-Qarakhli; Norhayati Yusop; Rachel J Waddington; Ryan Moseley
Journal:  BMC Mol Cell Biol       Date:  2019-11-21
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.